Department of Structural Biology, University of Pittsburgh School of Medicine, Biomedical Science Tower 3, 3501 Fifth Avenue, Pittsburgh, PA 15260, USA.
Department of Structural Biology, University of Pittsburgh School of Medicine, Biomedical Science Tower 3, 3501 Fifth Avenue, Pittsburgh, PA 15260, USA.
Methods. 2018 Sep 15;148:9-18. doi: 10.1016/j.ymeth.2018.04.005. Epub 2018 Apr 12.
This manuscript presents an NMR strategy to investigate conformational differences in protein-inhibitor complexes, when the inhibitors tightly bind to a protein at sub-nanomolar dissociation constants and are highly analogous to each other. Using HIV-1 protease (PR), we previously evaluated amide chemical shift differences, ΔCSPs, of PR bound to darunavir (DRV) compared to PR bound to several DRV analogue inhibitors, to investigate subtle but significant long-distance conformation changes caused by the inhibitor's chemical moiety variation [Khan, S. N., Persons, J. D. Paulsen, J. L., Guerrero, M., Schiffer, C. A., Kurt-Yilmaz, N., and Ishima, R., Biochemistry, (2018), 57, 1652-1662]. However, ΔCSPs are not ideal for investigating subtle PR-inhibitor interface differences because intrinsic differences in the electron shielding of the inhibitors affect protein ΔCSPs. NMR relaxation is also not suitable as it is not sensitive enough to detect small conformational differences in rigid regions among similar PR-inhibitor complexes. Thus, to gain insight into conformational differences at the inhibitor-protein interface, we recorded N-half filtered NOESY spectra of PR bound to two highly analogous inhibitors and assessed NOEs between PR amide protons and inhibitor protons, between PR amide protons and hydroxyl side chains, and between PR amide protons and water protons. We also verified the PR amide-water NOEs using 2D water-NOE/ROE experiments. Differences in water-amide proton NOE peaks, possibly due to amide-protein hydrogen bonds, were observed between subunit A and subunit B, and between the DRV-bound form and an analogous inhibitor-bound form, which may contribute to remote conformational changes.
本文提出了一种 NMR 策略,用于研究在抑制剂以亚纳摩尔离解常数紧密结合至蛋白质且高度类似的情况下,蛋白质-抑制剂复合物中的构象差异。我们先前使用 HIV-1 蛋白酶 (PR) 评估了与 darunavir (DRV) 结合的 PR 与几种 DRV 类似物抑制剂结合时酰胺化学位移差异 (ΔCSPs),以研究由于抑制剂化学部分的变化而引起的细微但显著的长程构象变化 [Khan, S. N., Persons, J. D. Paulsen, J. L., Guerrero, M., Schiffer, C. A., Kurt-Yilmaz, N., and Ishima, R., Biochemistry, (2018), 57, 1652-1662]。然而,ΔCSPs 并不适合研究细微的 PR-抑制剂界面差异,因为抑制剂的电子屏蔽的固有差异会影响蛋白质的 ΔCSPs。NMR 弛豫也不适合,因为它不够灵敏,无法检测类似的 PR-抑制剂复合物中刚性区域的微小构象差异。因此,为了深入了解抑制剂-蛋白质界面的构象差异,我们记录了与两种高度类似的抑制剂结合的 PR 的 N-半滤波 NOESY 谱,并评估了 PR 酰胺质子与抑制剂质子、PR 酰胺质子与羟基侧链之间以及 PR 酰胺质子与水质子之间的 NOE。我们还使用 2D 水-NOE/ROE 实验验证了 PR 酰胺-水 NOE。在亚基 A 和亚基 B 之间以及 DRV 结合形式和类似物结合形式之间观察到水-酰胺质子 NOE 峰的差异,这可能是由于酰胺-蛋白质氢键的差异,这可能导致远程构象变化。